CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population

Depression disorder is one of the most serious mental illnesses in the world. Escitalopram is the essential first-line medication for depression disorder. It is the substrate of hepatic cytochrome P450 (CYP) enzyme CYP2C19 with high polymorphism. The effect of CYP2C19 on pharmacokinetics and pharmac...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xinyi, Li, Chao, Li, Chaopeng, Li, Zhenyu, Li, Xiaohui, Liao, Jianwei, Rao, Tai, Chen, Lulu, Gao, Lichen, Ouyang, Dongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429954/
https://www.ncbi.nlm.nih.gov/pubmed/34512354
http://dx.doi.org/10.3389/fphar.2021.730461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429954/
https://www.ncbi.nlm.nih.gov/pubmed/34512354
http://dx.doi.org/10.3389/fphar.2021.730461

Ejemplares similares